Tricuspid regurgitation risk model study

This trial uses safe, non-invasive tests to study people with moderate or severe tricuspid regurgitation (leaky valve on the right side of the heart). It aims to better understand the condition, which may lead to improved care in the future.

This study is a registry that collects data on patients who receive a new type of heart valve replacement for the tricuspid valve through a less invasive catheter procedure. Joining helps doctors learn more about how well this treatment works in real-world patients.

This study focuses on people with severe “tricuspid regurgitation,” which means a valve in the right side of the heart leaks backward. It collects information (including interviews) to better understand this condition and what to do next.

This study is collecting information about people with severe tricuspid regurgitation (a leaky heart valve) who are having a catheter-based repair. The goal is to better understand these patients and how well the procedure works for them.

This study tests a new, catheter-based procedure to treat moderate-to-severe leaking of the tricuspid valve (a heart valve on the right side). It’s for people who are high surgical risk and might benefit from replacing the valve without open-heart surgery.

This trial studies whether a minimally invasive “clip” procedure can safely improve tricuspid valve leakage (a heart valve that doesn’t close tightly). It focuses on older adults who are considered too high-risk for open-heart surgery and still have enough heart pumping strength to benefit.